Longitudinal study of interleukin-10, tumor necrosis factor- α, anti-U1-snRNP antibody levels and disease activity in patients with mixed connective tissue disease

References

• Sharp GC, Irvin WS, Tan EM, Jolla L, Gould GR, Holmand HR. Mixed connective tissue disease; An apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972;52:148–59.
   PubMed Web of Science ®Google Scholar
• Reichlin M, Van Venrooij WJ. Autoantibodies to the URNP particles: relationship to clinical diagnosis and nephritis. Clin Exp Immunol 1999;83:286–90.
   Google Scholar
• Fujinami M, Saito K, Okawa-Takatsuji M, Kotajima L, Kinoshita M, Sumiya M, et al. Histological evaluation of destructive monoarthropathy in mixed connective tissue disease. Scand J Rheumatol 1997;26:395–8.
   Google Scholar
• Sharp GC, Irvin WS, May CM, Holman HR, McDuffie FC, Hess EV, et al. Association of antibodies to riboneucleoprotein and Sm antigens with Mixed Connective-Tissue Disease, Systemic Lupus Erythematosus and other rheumatic diseases. N Eng J Med 1976;295:1149–54.
   PubMed Web of Science ®Google Scholar
• Tan EM. Antinuclear antibodies. Diagnostic markers for auto-immune diseases and probes for cell biology. Adv Immunol 1989;44:93–120.
   PubMed Web of Science ®Google Scholar
• Lundberg I, Hedfors E. Clinical course of patients with anti-RNP antibodies. A prospective study of 32 patients. J Rheumatol 1991;18:1511–9.
   Google Scholar
• Bennett RM, O'Connell DJ. Mixed Connective Tissue Disease; A clinicopathologic Study of 20 Cases. Semin Arthritis Rheum 1980;10:25–51.
   PubMed Web of Science ®Google Scholar
• Llorente L, Richaud-Patin Y, Fior R, Alcocer-Varela J, Wijdenes J, Fourrier BM, et al. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjogren's syndrome, and systemic lupus erythematosus: a potential mech-anism of B lymphocyte hyperactivity and autoimmunity. Arthritis Rheum 1994;37:1647–55.
   PubMed Web of Science ®Google Scholar
• Llorente L, Zou W, Levy Y, Richaud-Patin Y, Wijdenes J, Alcocer-Varela J, et al. Role of interleukin-10 in the B lympho-cyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 1995;181: 839–44.
   Google Scholar
• Barcellin W, Rizzardi G, Borghi M, Nicoletti F, Fain C, Del Papa N, et al. In vitro type-1 and type-2 cytokine production in systemic lupus erythematosus: Lack of relationship with clinical disease activity. Lupus 1996;5: 139–45.
   Google Scholar
• Cross JT, Benton HP. The roles of interleukin-6 and intereukin-10 in B cell hyperactivity in systemic lupus eryth-ematosus. Inflamm Res 1999;48:255–61.
   PubMedGoogle Scholar
• Gröndal G, Kristjansdottir H, Gunnlaugsdottir B, Arnason A, Lundberg I, Klareskog L, et al. Increased number of interleukin-10-producing cells in systemic lupus erythematosus patients and their first-degree relatives and spouses in Icelandic multicase families. Arthritis Rheum 1999;42: 1649–54.
   Google Scholar
• Llorente L, Richaud-Patin Y, Couderc J, Alarcon-Segovia D, Ruiz-Soto R, Alcocer-Castillejos N, et al. Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:1429–35.
   PubMed Web of Science ®Google Scholar
• Funauchi M, Ikoma S, Enomoto H, Horiuchi A. Decreased Thl-like and increased Th2-like cells in systemic lupus erythematosus. Scand J Rheumatol 1998;27:219–24.
   PubMed Web of Science ®Google Scholar
• Llorente L, Richaud-Patin Y, Wijdenes J, Alcocer-Varela J, Maillot M-C, Durand-Gasselin I, et al. Spontaneous produc-tion of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. Eur Cytokine Netw 1993;4:421–30.
   PubMed Web of Science ®Google Scholar
• Hassan AB, Rönnelid J, Gunnarsson I, Karlsson G, Berg L, Lundberg I. Increased serum levels of immunoglobulins, C-reactive protein, Type 1 and Type 2 cytokines in patients with mixed connective tissue disease. J Autoimmunity 1998;11:503–8.
   PubMedGoogle Scholar
• Saxne T, Palladino MA Jr, Heinegard D, Talal N, Wollheim FA. Detection of tumor necrosis factor a but not tumor necrosis factor p in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 1988;31:1041–5.
   PubMed Web of Science ®Google Scholar
• Maury CP, Teppo AM. Tumor necrosis factor in the serum of patients with systemic lupus erythematosus. Arthritis Rheum 1989;32:146–50.
   PubMedGoogle Scholar
• Studnicka-Benke A, Steiner G, Petera P, Smolen JS. Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus eryth-ematosus. Br J Rheumatol 1996;35:1067–74.
   Google Scholar
• Alarcon-Segovia D, Cardiel MH. Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol 1989;16: 328–34.
   Google Scholar
• Liang M, Socher S, Larson M, Schur P. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989;32:1107–18.
   PubMed Web of Science ®Google Scholar
• Pesce AJ, Michael JG. Artifacts and limitations of enzyme immunoassay. J Immunol Methods 1992;150:111–9.
   PubMed Web of Science ®Google Scholar
• Schonheyder H, Anderson P. Effects of bovine serum albumin on antibody determination by Enzyme-Linked Immuno-Sorbent Assay. J Immunol Methods 1984;72:251–9.
   PubMed Web of Science ®Google Scholar
• Anderson G, Ekre H-PT, Alm G, Perlmann P. Monoclonal antibody two-site ELISA for human IFN-y: Adaptation for determinations in human serum or plasma. J Immunol Methods 1989;125:89–96.
   Google Scholar
• Burdt MA, Hoffman RW, Deutscher SL, Wang GS, Johnson JC, Sharp GC. Long-term outcome in mixed connective tissue disease: Longitudinal clinical and serological findings. Arthritis Rheum 1999;42:899–909.
   PubMed Web of Science ®Google Scholar